Coulie P G, Cayphas S, Vink A, Uyttenhove C, Van Snick J
Eur J Immunol. 1987 Aug;17(8):1217-20. doi: 10.1002/eji.1830170821.
Serum of lipopolysaccharide (LPS)-treated mice was found to support the growth of interleukin-HP1 (HP1)-dependent hybridoma and plasmacytoma cell lines. This growth-promoting activity, which was undetectable in normal serum, rose more than 1000-fold within 2 h after i.v. injection of the toxin and disappeared in less than 1 day. It could be traced to a single component, which behaved like HP1 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and reverse phase high performance liquid chromatography, and was completely inhibited by a rabbit anti-HP1 antiserum. The LPS-induced factor was apparently not of T cell origin, as indicated by the strong activity found in the serum of LPS-treated nude mice. In vitro, LPS also considerably enhanced the production by macrophages of a factor with similar characteristics.
研究发现,经脂多糖(LPS)处理的小鼠血清能够支持依赖白细胞介素-HP1(HP1)的杂交瘤和浆细胞瘤细胞系的生长。这种促生长活性在正常血清中无法检测到,在静脉注射毒素后2小时内上升超过1000倍,并在不到1天内消失。它可追溯到单一成分,该成分在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和反相高效液相色谱中表现得与HP1相似,并被兔抗HP1抗血清完全抑制。LPS诱导的因子显然不是T细胞来源,这一点从LPS处理的裸鼠血清中发现的强活性可以看出。在体外,LPS也显著增强了巨噬细胞产生具有相似特征的因子的能力。